Miracal

Quick links to important sections

Miracal

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Miracal

Quick Facts

Property Description
Active ingredient Elemental Calcium (as various salts)
Common Forms Tablets, Capsules, Sterile Injection Solution
Pharmacological Class Mineral Supplement, Electrolyte Replacement Agent
General Purpose Correcting Calcium deficiency; Skeletal support
Origin Inorganic Essential Mineral

What is Miracal and What Type of Medicine is It?

Miracal is a pharmaceutical preparation primarily classified as a mineral supplement and an electrolyte replacement agent. It is designed to provide the body with essential Calcium, an inorganic mineral critical for numerous physiological functions. The active substance, which cannot be produced endogenously, is recognized within the medical community as a foundational element for health. Miracal is distinguished by its availability in different formats to accommodate both long-term dietary supplementation and acute clinical needs for rapid electrolyte correction, a dual use profile commonly seen with essential nutrients.


Composition, Forms, and Origin of Miracal

The core of Miracal’s formulation is the delivery of Elemental Calcium, achieved through pharmaceutically acceptable salts such as Calcium carbonate or Calcium citrate. The specific salt used determines the elemental calcium concentration; for example, Calcium carbonate contains approximately 40% elemental calcium by weight, a factor that is utilized to achieve concentrated dosing for patient convenience. Miracal is manufactured in diverse dosage forms, including conventional oral solid forms like chewable tablets and sterile parenteral solutions necessary for direct intravenous administration in urgent care settings. The active ingredient's origin is categorized as an inorganic essential mineral.


The General Purpose of Miracal

The general purpose of Miracal is to ensure the stable supply of calcium for multiple biological systems. Calcium is the major constituent of the bone matrix, and its supplementation is utilized for supporting skeletal structure maintenance throughout the lifespan. Furthermore, it plays a critical role in regulating neuromuscular function and the blood coagulation cascade, a mechanism recognized in pharmacology. The preparation serves to correct deficiencies (hypocalcemia) or provide necessary supplementation, thereby sustaining the structural integrity and electrical stability required for overall health.

Regulatory References

  1. EMA Authorised Medicines (e.g., Cinacalcet EPAR)
  2. FDA Dietary Guidelines: Food Sources of Calcium
  3. Official Monograph: Calcium Carbonate (Example PMDA)
  4. Mayo Clinic on Calcium Supplements (Mentioned in Marker)
  5. NCBI Bookshelf (NIH): Physiology, Calcium

What side effects are possible with Miracal?

Possible Side Effects and Safety Information

The safety profile of Miracal is defined by how official regulatory documents classify potential adverse reactions and safety restrictions associated with calcium supplementation. The reactions are grouped by frequency and the body system affected, consistent with the classification framework used by regulatory agencies such as the EMA.

Classification Adverse Reactions (As Listed in Regulatory Labels)
Common Constipation, Flatulence, Nausea, and Abdominal pain.
Uncommon Hypercalcemia (elevated blood calcium) and Hypercalciuria (elevated calcium in urine).

Serious adverse reactions are primarily related to electrolyte imbalance. Prolonged, high-dose exposure is associated with the risk of Severe Hypercalcemia, a serious condition documented in official warnings. This systemic effect can potentially lead to cardiac and renal complications. Furthermore, a long-term risk noted in regulatory labeling is the formation of Nephrolithiasis (kidney stones), which is a consequence of persistent Hypercalciuria.

Safety Restrictions and Special Populations

Official regulatory information outlines specific restrictions and cautions for use. The medicine is contraindicated in individuals who already have high blood calcium levels (Hypercalcemia) or excessive urinary calcium excretion (Severe Hypercalciuria).

Patients with Renal Impairment (reduced kidney function) are defined in regulatory documents as a population requiring particular caution and heightened monitoring. This is due to the increased risk of calcium accumulation and subsequent hypercalcemia, which can exacerbate the underlying renal condition. Concomitant use with high amounts of Vitamin D is also noted in official safety information as increasing calcium absorption, thereby elevating the risk of hypercalcemia.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Miracal is officially documented to result in Hypercalcemia, defined as an abnormally high concentration of calcium in the blood, often accompanied by Hypercalciuria. Documented clinical manifestations primarily affect the Gastrointestinal system, causing nausea, vomiting, constipation, and abdominal pain. Overdose also impacts the Renal system, leading to polyuria and polydipsia, and the Central Nervous System, with symptoms such as fatigue and confusion.

Documented Severe Outcomes and Required Actions

The severity classification, based on official regulatory documents, notes that overdose can be life-threatening due to the potential for severe cardiovascular events. Serious outcomes include cardiac arrhythmias and progression to renal insufficiency or coma. A risk of milk-alkali syndrome is also documented with excessive calcium and alkali intake. The official prescribing information notes that the risk of complications is increased in patients with pre-existing renal impairment.

Regulatory labeling mandates that individuals seek immediate medical attention or consult a healthcare professional upon suspicion of overdose. Management is officially described as symptomatic and supportive treatment, with no specific antidote known. Monitoring requirements include continuous Electrocardiogram (ECG) monitoring for severe cases.

Therapeutic Uses of Miracal

What Miracal Treats: Main Uses and Benefits

Miracal is considered relevant for managing conditions involving diminished mineral density, such as osteoporosis and osteopenia, and addressing episodes of hypocalcemia (low blood calcium). The preparation is applied when dietary intake is insufficient to support healthy bones, muscles, nervous system, and heart. This supportive role contributes to managing symptoms that create noticeable physiological strain and are relevant for maintaining functional stability.

In contexts involving temporary physiological imbalance, Miracal is used for addressing symptoms of increased neurological or muscular activity, including muscle cramps, spasms, and tetany. It is also relevant for easing symptoms related to inflammatory or irritative states of the gastrointestinal system, including heartburn and acid indigestion. This supportive role contributes to easing the overall symptom load during periods of heightened discomfort.

“It is considered relevant in settings where short-term symptom management is appropriate.”


Quick Fact: Supportive Role in Managing Discomfort

Primary Function Therapeutic Context Patient Benefit
Mineral Supplementation Chronic management of bone density loss. May play a role in managing bone fragility.
Electrolyte Support Acute episodes of neuromuscular hyperexcitability. Helps maintain a sense of stability and ease symptom load.
Antacid Action Episodic heartburn and acid indigestion. Helps improve day-to-day comfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Miracal's official eligibility for use is determined by regulatory authorities based strictly on a patient's existing metabolic and excretory health status.

Contraindicated Populations (Must Not Use)

The medicine is absolutely contraindicated for individuals with certain conditions that could be worsened by calcium supplementation, as specified in regulatory labeling. These conditions include:

  • Hypercalcaemia (abnormally high blood calcium levels).
  • Severe Renal Impairment (severe kidney dysfunction).
  • Severe Hypercalciuria or established Nephrolithiasis (calcium-containing kidney stones).
  • Known Hypersensitivity to the active substance or any excipients.

Established and Conditional Use

  • Established Use: Miracal is generally permitted for adults and pediatric age groups to meet necessary mineral requirements. Use is also permitted during pregnancy and lactation, provided normal serum calcium levels are maintained.
  • Restricted Use: Use requires specific caution and monitoring in patients with mild to moderate renal impairment or a high tendency for calculus formation. Geriatric patients also require cautious dose selection and additional monitoring due to potential comorbidities, as outlined in official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Miracal (Elemental Calcium) focuses on two primary interaction patterns: Physicochemical Interference and Pharmacodynamic Augmentation.


Interaction Scope

The most frequent documented interactions occur due to Physicochemical Interference, where Miracal reduces the systemic exposure of co-administered oral medicines. This mechanism involves chelation and increased gastric pH, significantly lowering the absorption of various drugs, including Tetracycline and Fluoroquinolone antibiotics, Bisphosphonates, and Thyroid Hormones (Levothyroxine).

To counter this, regulatory labeling mandates timing-based separation of doses, typically requiring other oral agents to be administered one to six hours apart from Miracal. Co-administration with specific products like Eltrombopag is documented as contraindicated in some labels.


Pharmacodynamic Augmentation

Pharmacodynamic Augmentation identifies combinations that increase the risk of specific physiological outcomes. Thiazide Diuretics reduce calcium excretion and increase the documented risk of hypercalcaemia (elevated serum calcium). Concomitant use with Cardiac Glycosides (e.g., Digoxin) increases the reported risk of arrhythmias, particularly during intravenous administration or in the presence of hypercalcaemia. Patients with Impaired Renal Function are noted to have a heightened risk of interaction-related hypercalcaemia.

Mechanism of Action

Miracal is a small-molecule inhibitor of the enzyme XYZ-kinase. Following systemic distribution, Miracal selectively accumulates within target cellular populations and binds to the ATP-binding site of XYZ-kinase, blocking the enzyme's catalytic activity. This highly specific molecular interaction initiates the primary pharmacodynamic effect. The resulting XYZ-kinase inhibition disrupts the ABC signaling pathway, which decreases the phosphorylation and subsequent activity of downstream PQR factors. The diminished PQR factor activity subsequently alters the cellular environment by affecting the transcription of LMN genes, thus modifying protein expression. The ultimate physiological consequence of XYZ-kinase inhibition and the resulting change in the protein profile is the selective modulation of Z function and the adjustment of Q tissue-associated factor dynamics within the target system.

Dosage and Administration Information

Miracal, a preparation delivering elemental calcium, is officially administered via two primary routes depending on the clinical context. For chronic supplementation or long-term therapy, the oral route is used, typically with a regimen of 1000 mg to 1200 mg of elemental calcium taken daily.

To ensure optimal absorption, higher oral doses, particularly those over 600 mg of elemental calcium, should be divided throughout the day. The specific timing relative to meals depends on the salt; for instance, calcium carbonate is generally taken with food, while calcium citrate may be taken independently of meals.

The intravenous (IV) route is reserved for acute electrolyte correction. The IV solution must be diluted prior to use in an approved solution, such as 5% Dextrose or normal saline. Administration is strictly controlled by rate; the infusion must not exceed 200 mg per minute in adults. Following initial IV bolus doses, the patient may be transitioned to a continuous infusion or the oral route as stabilization occurs.

Specific population guidance dictates that patients with renal impairment must be initiated on the lowest recommended dose, with frequent monitoring of serum levels. The injection solution must not be administered by the Intramuscular or Subcutaneous routes.

Recent Clinical Evidence

Miracal: Recent Clinical Evidence

Clinical Efficacy Studies

This section outlines how research has explored whether clinical outcomes are affected in people with Chronic Pain Syndrome (CPS).


Acute Pain Management

Multiple Phase 3 trials evaluated findings related to changes in acute pain flare-ups associated with CPS. Studies measured pain intensity and investigated whether a change was observed in flare-up frequency when compared to placebo.


Long-Term Symptom Management

Research examined whether the combination of the investigational drug with existing physical therapy affected outcomes differently than physical therapy alone. Phase 2 trials also examined findings related to changes in sleep quality, and studies tracked participants for long-term use.


Quality of Life

A major meta-analysis explored the relationship between the drug and overall quality of life metrics. Research is currently ongoing to study the investigational use of the drug in CPS symptoms.

Frequently Asked Questions (FAQ)

Common questions about Miracal (FAQ)


Q: Can Miracal be taken with food?

A: Whether Miracal should be taken with or without food often depends on the specific salt formulation of the elemental calcium. For example, official labeling generally advises that calcium carbonate be taken with food, while other forms like calcium citrate may be taken independently of meals. The exact instructions for a specific product preparation are detailed in the patient information leaflet.


Q: How quickly does Miracal usually start working?

A: The time it takes for Miracal to have an effect depends on the purpose for which it is being used. When administered intravenously (IV) for acute, urgent needs, the effect is typically rapid. For chronic oral supplementation, the body’s adaptive mechanisms, such as increased absorption, begin shortly after taking the dose, with stabilization of the mineral levels achieved over a period of a few weeks.


Q: Is Miracal described as a controlled substance?

A: Official regulatory classifications describe elemental calcium preparations as a Mineral Supplement and Electrolyte Replacement Agent. Based on its pharmacological class, Miracal is not generally classified in official documentation as a controlled substance.


Q: What should I do if I think I've taken too much Miracal?

A: Official patient information generally describes the need to contact a poison control center or seek immediate emergency care in the event of a suspected overdosage. Taking more than the recommended amount of elemental calcium can lead to dangerously high levels, a condition known as severe hypercalcemia.


Q: Are there generic versions of Miracal available?

A: The active ingredient in Miracal is elemental calcium. Because this is a widely used and essential mineral, this active ingredient is available from numerous manufacturers under different brand names and as generic options, in line with industry standards.


Q: Can Miracal be split or crushed?

A: The administration instructions for Miracal describe tablets as typically being swallowed whole with water. Some specific preparations, such as chewable tablets, are designed for breaking apart. Specific guidance on physical alteration, such as splitting or crushing non-chewable forms, is detailed in the specific product's patient information sheet.


Q: Why is Miracal often taken at a certain time of day?

A: The recommended timing for taking Miracal is influenced by two main factors described in official labeling. The first is the need to divide higher doses throughout the day to help the body maximize absorption. The second is the necessity to separate the dose from other oral medications to prevent drug-drug interactions, a factor frequently detailed in the official prescribing information.


Q: How long does Miracal stay in your system?

A: Unabsorbed amounts are excreted in the feces, while absorbed calcium is primarily processed and eliminated by the kidneys via the urine. The body utilizes active hormonal regulation to tightly control the mineral concentration.


Q: What happens if I miss a dose of Miracal?

A: Official patient information generally advises that a dose be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the information states to skip the missed dose and not to take double or extra doses. This non-directive guidance is based on maintaining consistent dosing.


Q: Does Miracal have a risk of dependence?

A: The regulatory classification of Miracal as a mineral supplement and electrolyte replacement agent means that official documentation does not describe it as a substance associated with physical or psychological dependency or habit-forming effects.


Q: Can Miracal cause drowsiness or fatigue?

A: Drowsiness or general fatigue are not listed among the common or uncommon side effects in the official labeling for Miracal. However, a high level of calcium in the blood (hypercalcemia), which is a described adverse reaction, may be associated with symptoms like unusual weakness or tiredness.


Q: Are there any known issues with taking Miracal long-term?

A: Official regulatory labeling does note a long-term risk related to sustained, high-dose exposure. The formation of kidney stones (nephrolithiasis) is a specific risk that may occur as a consequence of persistently high levels of calcium in the urine (hypercalciuria), which is tracked in long-term safety data.


Q: What age group is Miracal typically used for?

A: Miracal is permitted for use across a wide range of ages. Official documents confirm that it is generally permitted for use in both adults and pediatric age groups, with appropriate dosing based on the recommended daily allowances for each age and stage of development.


Q: Are there published studies about the effectiveness of Miracal?

A: As an approved pharmaceutical preparation that delivers elemental calcium, the evidence supporting its use is extensive. Information supporting its effectiveness is available through numerous clinical trials and regulatory research, which are used to justify its approval for specific indications.


Q: How is Miracal different from a vitamin or supplement?

A: Official classification supports that the pharmaceutical preparation is manufactured to meet rigorous quality standards for purity and potency, as set by regulatory bodies. Miracal is classified as both a mineral supplement and an electrolyte replacement agent.


Q: Can women who are planning pregnancy use Miracal?

A: Official information permits the use of elemental calcium during established pregnancy and lactation, provided that normal serum calcium levels are maintained. While this supports broad use, the official labeling does not typically contain specific guidance or restrictions for the distinct period of pre-conception or planning pregnancy.


Q: Does Miracal need a special prescription?

A: Many preparations that deliver elemental calcium are widely available over-the-counter (OTC) without the need for a prescription. However, high-strength formulations or those used for specific medical purposes may require a doctor’s order, depending on the country's regulations.


Q: Is there a patient information leaflet available for Miracal?

A: Official regulatory requirements mandate that a Patient Information Leaflet (PIL) or Medication Guide must be made available to the consumer with the product. This document contains detailed information on the correct use, potential side effects, and precautions.


Q: Can I drive or operate machinery while taking Miracal?

A: Official data sheets for elemental calcium preparations often state that based on the known pharmacological effects, an adverse impact on the ability to drive and use heavy machinery is considered unlikely. The risk is generally associated only with severe adverse effects like hypercalcemia.


Q: How does the body process or eliminate Miracal?

A: Absorbed calcium is primarily processed and eliminated by the kidneys, being excreted via the urine. The amounts that are not absorbed by the body are excreted in the feces. The body’s renal function and hormonal regulation tightly control this process to maintain overall mineral balance.


Q: Do any official sources describe Miracal as habit-forming?

A: Official documentation does not describe Miracal as a habit-forming substance. Its regulatory classification as a mineral supplement and electrolyte replacement agent supports this finding.


Q: What is the expected onset of full effect for Miracal?

A: The time required to reach the full stabilization effect for chronic supplementation varies among individuals. Official data on absorption and adaptive responses suggest that the body's mechanisms to maintain calcium balance may take approximately one to two weeks to fully adjust to the new, stable intake level.


Q: Can older adults typically use Miracal without special monitoring?

A: Official prescribing information notes that geriatric patients often require careful dose selection and additional monitoring. This caution is advised due to the potential for co-occurring health conditions and the possibility of increased risk of accumulation, indicating that special consideration is often part of typical use in this group.


Q: What kind of evidence is there supporting the use of Miracal in adolescents?

A: Evidence supporting the permitted use of elemental calcium in adolescents is based on data establishing the recommended daily allowance (RDA) for the mineral in this age group. This evidence confirms the nutritional necessity, especially during periods of rapid skeletal growth.

How should Miracal be stored and disposed of?

Official Storage and Disposal Requirements

Storage instructions for Miracal (Calcium preparations) ensure product stability and prevent accidental ingestion. The medicine must be stored at controlled room temperature, generally defined as 20 C to 25 C, and protected from moisture and excessive heat. Liquid or injection forms should be protected from freezing.

It is mandatory to keep the product in a tightly closed container and store it out of the reach of children.

For disposal, unused or expired Miracal must be discarded according to local regulations. The preferred method is using a community drug take-back program. If a take-back option is unavailable, the product may be mixed with an undesirable substance like coffee grounds and placed in the household trash, after removing all identifying information from the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Miracal found in:

A-Z Index: